Advaxis Combination Trial with Merck Completes First Two Dose-Escalation Cohorts
Go back to Advaxis Combination Trial with Merck Completes First Two Dose-Escalation Cohorts| ADVAXIS (AMEX: ADXS) | Delayed: 0.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.60 | 52 Week High | $16.30 | |||
| Open | $0.60 | 52 Week Low | $5.21 | |||
| Day High | $0.60 | P/E | N/A | |||
| Day Low | $0.60 | EPS | $-4.10 | |||
| Volume | 29,697,608 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 120.76 +1.67 (1.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $119.09 | 52 Week High | $65.46 | |||
| Open | $120.04 | 52 Week Low | $47.97 | |||
| Day High | $122.71 | P/E | 82.15 | |||
| Day Low | $119.95 | EPS | $1.47 | |||
| Volume | 13,179,268 | |||||
